Esophageal Carcinoma: Better Survival with Nivolumab in the Second Line Therapy

Kessing Richard

首页> 外文期刊>Zeitschrift fur Gastroenterologie >Esophageal Carcinoma: Better Survival with Nivolumab in the Second Line Therapy

【24h】

Esophageal Carcinoma: Better Survival with Nivolumab in the Second Line Therapy

机译：食管癌：在第二线疗法中与Nivolumab更好地存活

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Zeitschrift fur Gastroenterologie》 |2020年第2期|共1页
作者
Kessing Richard;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 ger
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Esophageal Carcinoma: Better Survival with Nivolumab in the Second Line Therapy [J] . Kessing Richard Zeitschrift fur Gastroenterologie . 2020,第2期

机译：食管癌：在第二线疗法中与Nivolumab更好地存活
2. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial [J] . Kato Ken, Cho Byoung Chul, Takahashi Masanobu, The lancet oncology . 2019,第11期

机译：Nivolumab与晚食管鳞状细胞癌患者的化疗对之前的化疗（吸引-3）：多期，随机，开放标签，第3阶段试验
3. Benefit–Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based Chemotherapy [J] . Lorraine Pelosof, Maryam Khazraee, Kirsten B. Goldberg, The oncologist . 2021,第4期

机译：富含氟嘧啶和铂基化疗后，Nivolumab治疗未切除先进，复发性或转移性食管鳞状细胞癌的益处风险概述
4. Results and survival after photodynamic therapy in early-stage esophageal carcinoma [C] . Pasquale Spinelli, Istituto Nazionale Tumori, Milano, Medical Applications of Lasers III . 1996

机译：早期食管癌光动力治疗后的结果和生存
5. Development of an efficient, smart, and portable photonic light delivery system for use in photodynamic therapy of esophageal carcinoma. [D] . Premasiri, Amaranath. 2008

机译：开发一种高效，智能和便携式的光子光传输系统，用于食道癌的光动力治疗。
6. Change in Maximal Esophageal Wall Thickness Provides Prediction of Survival and Recurrence in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy and Surgery [O] . Yahua Wu, Jiancheng Li 2021

机译：最大食管壁厚的变化提供了在Neoadjuvant ChearoRadiotherapy和手术后食管鳞状细胞癌患者的存活率和复发的预测
7. Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3) [O] . Masanobu Takahashi, Ken Kato, Morihito Okada, 2020

机译：日本患者的Nivolumab与化疗晚期食管鳞状细胞癌：多中心，随机，开放标签，第3阶段试验的亚组分析（吸引力-3）

Esophageal Carcinoma: Better Survival with Nivolumab in the Second Line Therapy

著录项

相似文献

相关主题

期刊订阅